FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2097600612> ?p ?o ?g. }

• W2097600612 endingPage "34" @default.
• W2097600612 startingPage "729" @default.
• W2097600612 abstract "Urinary tract infections (UTIs) are very common and have been treated with apparent success with antimicrobials for many years. However, there is a paucity of placebo-controlled clinical trials.To measure the symptomatic and bacteriological short-term effect of nitrofurantoin treatment versus placebo, in the treatment of uncomplicated UTI in adult non-pregnant women.Randomised placebo-controlled trial in general practice.Non-pregnant women, aged between 15 and 54 years old, consulting a general practitioner for symtoms suggestive of uncomplicated lower UTI and with pyuria (positive for leucocyte esterase test).A dipslide was inoculated in first-void midstream urine and sent for examinion. The patients were randomised to receive nitrofurantoin 100 mg or placebo four times daily for three days. After three, seven, and 14 days a new dipslide was inoculated and symptoms of UTI were checked or improvement of symptoms and bacteriuria.Of 166 women consulting with symptoms suggestive for UTI, 78 had pyuia and agreed to participate in the study (the clinically suspected UTI group); of these, 40 received nitrofurantoin and 38 received placebo. The result for combined symptomatic improvement and cure after three days was 27/35 in the nitrofurantoin group and 19/35 in the placebo group (c2 with Yates' correction P = 0.008; number needed to treat [NNT] = 4.4, 95% confidence interval [CI] = 2.3 to 79). After seven days, combined improvement and cure was observed in 30/34 and 17/33 respectively (P = 0.003, NNT = 2.7, 95% CI = 1.8 to 6.0). At inclusion, 56 women had bacteriuria of > or = 10(5) CFU/ml (the bacteriologically proven UTI group). Of these, 29 received nitrofurantoin and 27 received placebo. After three days the bacteriological cure was 21/26 in the treatment group, compared with 5/25 in the placebo group (P < 0.001; NNT = 1.6, 95% CI= 1.2 to 2.6). After seven days the bacteriological cure rate was 17/23 in the intervention group and 9/22 in the placebo group (P = 0.05, NNT = 3, 95% CI = 1.7 to 17).In women with bacteriologically proven UTI, nitrofurantoin was significantly more effective than placebo in achieving bacteriological cure and symptomatic relief in just three days; this was still present after seven days. In patients with clinically suspected UTI the symptomatic effect was statistically significant after" @default.
• W2097600612 created "2016-06-24" @default.
• W2097600612 creator A5033084690 @default.
• W2097600612 creator A5052914265 @default.
• W2097600612 creator A5067370682 @default.
• W2097600612 creator A5068090752 @default.
• W2097600612 creator A5083738182 @default.
• W2097600612 creator A5088835433 @default.
• W2097600612 date "2002-09-01" @default.
• W2097600612 modified "2023-10-01" @default.
• W2097600612 title "Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women." @default.
• W2097600612 cites W1527344135 @default.
• W2097600612 cites W169617614 @default.
• W2097600612 cites W1712298 @default.
• W2097600612 cites W1899296536 @default.
• W2097600612 cites W1914502777 @default.
• W2097600612 cites W1968545711 @default.
• W2097600612 cites W1982900907 @default.
• W2097600612 cites W2015412747 @default.
• W2097600612 cites W2062264724 @default.
• W2097600612 cites W2077723759 @default.
• W2097600612 cites W2083136436 @default.
• W2097600612 cites W2087981374 @default.
• W2097600612 cites W2121014417 @default.
• W2097600612 cites W2130316149 @default.
• W2097600612 cites W2161630897 @default.
• W2097600612 cites W2322428508 @default.
• W2097600612 cites W2322617269 @default.
• W2097600612 cites W2323054812 @default.
• W2097600612 cites W2332961262 @default.
• W2097600612 cites W2409331174 @default.
• W2097600612 cites W28462749 @default.
• W2097600612 cites W2062471595 @default.
• W2097600612 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1314413" @default.
• W2097600612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12236276" @default.
• W2097600612 hasPublicationYear "2002" @default.
• W2097600612 type Work @default.
• W2097600612 sameAs 2097600612 @default.
• W2097600612 citedByCount "99" @default.
• W2097600612 countsByYear W20976006122012 @default.
• W2097600612 countsByYear W20976006122013 @default.
• W2097600612 countsByYear W20976006122014 @default.
• W2097600612 countsByYear W20976006122015 @default.
• W2097600612 countsByYear W20976006122016 @default.
• W2097600612 countsByYear W20976006122017 @default.
• W2097600612 countsByYear W20976006122018 @default.
• W2097600612 countsByYear W20976006122019 @default.
• W2097600612 countsByYear W20976006122020 @default.
• W2097600612 countsByYear W20976006122021 @default.
• W2097600612 countsByYear W20976006122022 @default.
• W2097600612 countsByYear W20976006122023 @default.
• W2097600612 crossrefType "journal-article" @default.
• W2097600612 hasAuthorship W2097600612A5033084690 @default.
• W2097600612 hasAuthorship W2097600612A5052914265 @default.
• W2097600612 hasAuthorship W2097600612A5067370682 @default.
• W2097600612 hasAuthorship W2097600612A5068090752 @default.
• W2097600612 hasAuthorship W2097600612A5083738182 @default.
• W2097600612 hasAuthorship W2097600612A5088835433 @default.
• W2097600612 hasConcept C126322002 @default.
• W2097600612 hasConcept C141071460 @default.
• W2097600612 hasConcept C142724271 @default.
• W2097600612 hasConcept C168563851 @default.
• W2097600612 hasConcept C204787440 @default.
• W2097600612 hasConcept C27081682 @default.
• W2097600612 hasConcept C2776216170 @default.
• W2097600612 hasConcept C2777629877 @default.
• W2097600612 hasConcept C2778512257 @default.
• W2097600612 hasConcept C501593827 @default.
• W2097600612 hasConcept C71924100 @default.
• W2097600612 hasConcept C77411442 @default.
• W2097600612 hasConcept C86803240 @default.
• W2097600612 hasConcept C89423630 @default.
• W2097600612 hasConceptScore W2097600612C126322002 @default.
• W2097600612 hasConceptScore W2097600612C141071460 @default.
• W2097600612 hasConceptScore W2097600612C142724271 @default.
• W2097600612 hasConceptScore W2097600612C168563851 @default.
• W2097600612 hasConceptScore W2097600612C204787440 @default.
• W2097600612 hasConceptScore W2097600612C27081682 @default.
• W2097600612 hasConceptScore W2097600612C2776216170 @default.
• W2097600612 hasConceptScore W2097600612C2777629877 @default.
• W2097600612 hasConceptScore W2097600612C2778512257 @default.
• W2097600612 hasConceptScore W2097600612C501593827 @default.
• W2097600612 hasConceptScore W2097600612C71924100 @default.
• W2097600612 hasConceptScore W2097600612C77411442 @default.
• W2097600612 hasConceptScore W2097600612C86803240 @default.
• W2097600612 hasConceptScore W2097600612C89423630 @default.
• W2097600612 hasIssue "482" @default.
• W2097600612 hasLocation W20976006121 @default.
• W2097600612 hasOpenAccess W2097600612 @default.
• W2097600612 hasPrimaryLocation W20976006121 @default.
• W2097600612 hasRelatedWork W1581936402 @default.
• W2097600612 hasRelatedWork W1974347629 @default.
• W2097600612 hasRelatedWork W2005142303 @default.
• W2097600612 hasRelatedWork W2009008133 @default.
• W2097600612 hasRelatedWork W2041584443 @default.
• W2097600612 hasRelatedWork W2048891403 @default.
• W2097600612 hasRelatedWork W3009124764 @default.
• W2097600612 hasRelatedWork W3033054950 @default.

• next